Zura Bio Limited Stock Today

ZURA Stock   3.57  0.08  2.29%   

Performance

2 of 100

 
Weak
 
Strong
Weak

Odds Of Distress

Less than 31

 
High
 
Low
Below Average
Zura Bio is trading at 3.57 as of the 23rd of July 2024, a 2.29 percent up since the beginning of the trading day. The stock's open price was 3.49. Zura Bio has about a 31 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Zura Bio Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of June 2024 and ending today, the 23rd of July 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
3rd of September 2021
Category
Healthcare
Classification
Health Care
Zura Bio is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 63.68 M outstanding shares of which 710.07 K shares are at this time shorted by private and institutional investors with about 3.05 trading days to cover. More on Zura Bio Limited

Moving against Zura Stock

  0.31IKNA Ikena OncologyPairCorr

Zura Stock Highlights

President COORobert Lisicki
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.02010.0226
Fairly Down
Slightly volatile
Total Current Liabilities12.9 M20.3 M
Way Down
Slightly volatile
Non Current Liabilities Total940.5 K990 K
Notably Down
Slightly volatile
Total Assets90.6 M100.8 M
Moderately Down
Slightly volatile
Total Current Assets105.9 M100.8 M
Sufficiently Up
Slightly volatile
Debt Levels
Zura Bio can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Zura Bio's financial leverage. It provides some insight into what part of Zura Bio's total assets is financed by creditors.
Zura Bio Limited (ZURA) is traded on NASDAQ Exchange in USA. It is located in 1489 W. Warm Springs Road, Henderson, NV, United States, 89014 and employs 14 people. Zura Bio is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 208.25 M. Zura Bio Limited conducts business under Biotechnology sector and is part of Health Care industry. The entity has 63.68 M outstanding shares of which 710.07 K shares are at this time shorted by private and institutional investors with about 3.05 trading days to cover. Zura Bio generates negative cash flow from operations
Check Zura Bio Probability Of Bankruptcy
Ownership Allocation
Zura Bio Limited retains a total of 63.68 Million outstanding shares. Zura Bio Limited owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Zura Ownership Details

Zura Bio Historical Income Statement

View More Fundamentals

Zura Stock Against Markets

Zura Bio Corporate Management

Gary WhaleChief OfficerProfile
David BradyHead DevelopmentProfile
Kiran MBBSChief DevelopmentProfile
Kimberly DavisChief SecretaryProfile
Theresa LowryChief OfficerProfile
Verender BadialChief OfficerProfile
Michael HowellChief ScienceProfile

Already Invested in Zura Bio Limited?

The danger of trading Zura Bio Limited is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zura Bio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zura Bio. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zura Bio Limited is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

Additional Information and Resources on Investing in Zura Stock

When determining whether Zura Bio Limited is a strong investment it is important to analyze Zura Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zura Bio's future performance. For an informed investment choice regarding Zura Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zura Bio Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. If investors know Zura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zura Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.65
Return On Assets
(0.59)
Return On Equity
(1.04)
The market value of Zura Bio Limited is measured differently than its book value, which is the value of Zura that is recorded on the company's balance sheet. Investors also form their own opinion of Zura Bio's value that differs from its market value or its book value, called intrinsic value, which is Zura Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zura Bio's market value can be influenced by many factors that don't directly affect Zura Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zura Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zura Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.